Status:
UNKNOWN
Propofol for Sedation of Postoperative Electively Ventilated Liver Transplant Recipients.
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Liver Cirrhoses
Eligibility:
All Genders
18-70 years
Brief Summary
All consenting, adult patients aged 18 years and above who will require elective ventilation after liver transplant recipient surgery will be enrolled for the study. Patients in acute liver failure, h...
Eligibility Criteria
Inclusion
- • Living donor liver transplant (LDLT) recipient adult patients ≥ 18 years of age requiring postoperative elective ventilation.
Exclusion
- Propofol allergy
- Acute liver failure (ALF).
- Hepatic encephalopathy (HE)
Key Trial Info
Start Date :
January 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03837145
Start Date
January 12 2019
End Date
March 31 2019
Last Update
February 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of liver and biliary sciences
New Delhi, National Capital Territory of Delhi, India, 110070